Sun Asks India Supreme Court To Lift State Court's Stay Of Ranbaxy Merger
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries filed an appeal to India's Supreme Court to overturn a stay on its merger with Ranbaxy Laboratories ordered by the Andhra Pradesh High Court after insider-trading allegations were made.